BayMark Health Services, a portfolio company of Webster Equity Partners (formerly known as Webster Capital), is still on the acquisition trail, even as it is reportedly prepping for a sales process.

In its first deal announced in 2019, BayMark targeted Recovery Services of New Mexico, based in Albuquerque. Recovery Services offers opioid treatment programs for patients around the state. It has three traditional opioid treatment programs, one office-based treatment program and a fifth location inside of Bernalillo County Metropolitan Detention Center.

BayMark provides medication-assisted treatment for opiate addiction and dependency to thousands of patients nationwide. It is the largest opioid treatment company in North America with 218 programs across 32 states and one Canadian province. Since August 2016, BayMark has announced 15 transactions, not one of which disclosed a price.

In January, Webster engaged Goldman Sachs to advise on a sales process, according to Buyouts Insider. No word on how that’s going, but there are sure to be some interested parties kicking the tires.